The Journal of Biomedical Science (JBS,
The performance of the journal not only marks the best among similar journals produced domestically but also keeps abreast of the competition in Asia.
According to the ISI, impact factor of JBS last year is 2.322, which ranks the 933rd among 5,876 journals. Impact factor for a specific year is defined as the total number of citations made in that year for articles published in two previous years divided by the number of citable articles published in these years.
The ISI Journal Citation Reports identifies itself as "a unique multidisciplinary database ideal for a broad range of practical applications by a variety of information professionals. It presents quantifiable statistical data that provides a systematic, objective way to determine the relative importance of journals within their subject categories," on its Web site.
According to the NSC, the performance of JBS ranks the 4th among 279 science journals published by Asian countries. The local publication follows, DNA Research, and Microbes Infect published in Japan and World Journal of Castroenterology of China in rank.
"We should feel excited about the news because our efforts in the past decade made the journal globally recognized," Lin Fou-lai (林福來), director of the NSC's Department of Science Education, said.
Established in 1994, JBS is an international forum devoted to the promotion of basic medical science and its significance for human welfare. Encouraging interdisciplinary dialogue between basic and clinical researchers, it aims to clarify the molecular mechanisms involved in the pathogenesis of diseases and to provide the basis for their treatment.
Although primarily devoted to original research papers, the journal also features regular reviews on current topics of special interest. In September, 1996, world class science journal Nature introduced JBS to readers, stressing that "reviews are well written and timely with an emphasis on clinical-basic sciences issues."